Inventor · disambiguated record
Hang Chu
Also filed as: CHU HANG
16 granted patents·9 pending applications·85 citations·filing 2019–2025
92Inventor score
Top patents by PatentIndex Score
25 records- 0197US11613546B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Mar 28, 2023·9 cites·44 claims
- 0297US11548902B1Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2021·Granted Jan 10, 2023·7 cites·60 claims
- 0397US11084832B2Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2020·Granted Aug 10, 2021·25 cites·47 claims
- 0497US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0596US11897892B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Feb 13, 2024·6 cites·35 claims
- 0696US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0796US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0895US12024528B2Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 2, 2024·6 cites·28 claims
- 0993US12187734B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jan 7, 2025·1 cites·27 claims
- 1093US12054496B2Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Aug 6, 2024·2 cites·30 claims
- 1192US12404262B2Therapeutic compounds for HIV virus infectionGILEAD SCIENCES INC·Filed 2022·Granted Sep 2, 2025·1 cites·22 claims
- 1292US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 1387US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1485US2025188089A1Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1583US2025115619A1Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1682US12227520B2Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2022·Granted Feb 18, 2025·0 cites·8 claims
- 1782US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 1881US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1978US2024246975A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2077US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 2175US2025115620A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2272US12421235B2Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Sep 23, 2025·0 cites·22 claims
- 2351US2024409609A1Reversible lysine covalent modifiers of egfr and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2442US2025289789A1Reversible lysine covalent modifiers of cdk2 and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2541US2025289820A1Non-covalent modifiers of akt1 and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hang Chu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →